Efficacy of advanced radiotherapy (ART) in gynecological cancer patients (GYN-ART)
NCT ID NCT06306170
First seen Oct 22, 2026 · Last updated Oct 23, 2026 · Updated 1 time
Summary
This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2024
- Expected to finish
-
Feb 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Gynecologic cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT
- Ages
-
18 to 90 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * gynecologic cancer patients * \>18 years old * treated with advanced radiotherapy techniques (IGRT, IMRT, SBRT) Exclusion Criteria: * other tumors * \> 90 years old
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gynecologic cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
San Raffaele Scientific Institute
RECRUITINGMilan, MI, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Toxicity and outcome of whole breast hypofractionated radiotherapy without boost: results of a homogeneous single institution experience
- Can zapping a few tumors help women with advanced gynecologic cancer?
- Watching engineered t cells for years to see if they stay safe and active
- Why does radiation burn some Patients' skin more than others?
- Can Home-Delivered meal kits help young cancer survivors eat better after treatment?
- Nerve stimulator probes hidden muscle relaxant risk in frail cancer surgery patients